Clinical trial
Pegfilgrastim (Neulasta) for Stem Cell Mobilization in Patients With Multiple…
NCT00067639 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00067639 |
|---|---|
| Title | Pegfilgrastim (Neulasta) for Stem Cell Mobilization in Patients With Multiple Myeloma |
| Official title | Pegfilgrastim (Neulasta) for Mobilization of Peripheral Blood Progenitor Cells (PBPC) in Patients With Multiple Myeloma |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Amgen Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug, Procedure |
| Interventions | Pegfilgrastim (Neulasta), Apheresis |
| Enrollment | 50 |
| Start date | Dec 1, 2003 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Aug 26, 2003 |
| Last update posted | Aug 1, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: